ARCHIVES

In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin

This article is from The Cancer Letter archive.

Vol. 03 No. 16 | April 22, 1977

Download PDF Visit The Full Archive

Related Articles

Possible Association Between Agent Orange, AML, IOM Says.

April 27, 2001

Medicare coverage and quality of care top ASCO’s list of policy priorities for 2004.

February 27, 2004

In Brief: Schepartz To Leave NCI for Academia; Woolley Names To Head Clinical Research At Lombardi

March 9, 1984

Center Review By Panel, NCI Leading To Changes; Hammer Tells NCAB It Faces “Difficult Decision”

December 13, 1984

Basic Biology Progress, Improved Survival Since 1971 Described By DeVita At Senate Hearing

February 27, 1981

Funding Opportunities.

April 11, 2003